Morbidity, mortality, and cost impact of stage b and stage c heart failure: comparative analysis to underline the clinical and economic need for heart failure prevention strategy.
21 May 2016 (00:00 - 00:00)
Organised by:
About the speaker
Mayo University Hospital Castlebar, Castlebar (Ireland)
13 More presentations in this session
Doctor G. Marazzi (Rome, IT)
MTP-131, a cardiolipin-targeting peptide, improves mitochondrial activity in the failing human heart
Doctor B. Stauffer (Aurora, US)
Doctor G. Rocha Rodrigues (Lisbon, PT)
Professor S. Stoerk (Wuerzburg, DE)
Access the full session
The Event
HEART FAILURE 2016
21 May - 24 May 2016
